Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy

Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy

Submitted by admin on February 9, 2024 - 11:13am
Source: 
Reuters
News Tags: 
Moderna Therapeutics
vaccines
RSV
clinical trials
Headline: 
Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy
snippet: 

Moderna (MRNA.O), shares fell 6% on Friday after a longer-term analysis of a trial indicated a quicker fall in the efficacy of its experimental respiratory syncytial virus (RSV) vaccine.

Do Not Allow Advertisers to Use My Personal information